Sickle cell disease (SCD) is an inherited, lifelong chronic disorder affecting nearly 100,000 Americans and a growing global health problem that will touch nearly 30 percent more people globally in the next three decades. Though new approaches to managing SCD have led to improvements in diagnosis and supportive care, people living with the disease still have severe complications to overcome. Many are unable to access quality care and are limited by a lack of effective treatment options.
In an effort to identify unmet medical needs for people with SCD, the American Society of Hematology (ASH), along with other groups, issued the State of Sickle Cell Disease: 2016 Report, evaluating the disease in four priority areas — access to care, training and professional education, research and clinical trials, and global health. The report shows that significant improvements are needed across all areas and that, though patients are living longer, the system of care needs to change to ensure a better quality of life. To address these challenges, ASH launched the Sickle Cell Disease Coalition along with more than 20 other organizations who are issuing a call to action that will amplify the voice of the SCD community, promote SCD awareness, and transform SCD care both in the United States and around the globe.
To view the multimedia release go to:
http://www.multivu.com/players/English/7903251-american-society-hematology-sickle-cell-coalition/
Leveraging 130 years of knowledge and expertise across the Johnson & Johnson Family of Companies, Johnson & Johnson Medical Devices (JJMD) is proud to launch a new approach to help drive value-based healthcare in hospitals across Europe, Middle East and Africa (EMEA) – CareAdvantage. This is a data-driven, holistic approach in which JJMD partners with hospitals and other healthcare providers to provide a range of benefits, tailored to the customer’s specific needs and priorities.
The healthcare marketplace is changing, with intensifying pressure to meet the ‘triple aim’ of improving outcomes, increasing patient satisfaction and reducing costs. As the focus shifts from volume to value, there is a growing need for new delivery models, resulting in rapid transformation for hospital systems, clinicians and their patients.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8119051-johnson-medical-devices-careadvantage/
GreatCall, Inc., a leader in wireless services that enable its customers to stay connected, safe and healthy, along with John Walsh, the creator and host of America’s Most Wanted, are working together to educate families on summer safety and how 5Star Urgent Response™ can help you be better prepared. Studies show that accidents and crime increase in the summer. As people become more relaxed on vacation, precautions and common sense can take a back seat to summer fun.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56086-greatcall-5star-urgent-response-john-walsh-america-s-most-wanted-host
HMR Weight Management Services Corp. (HMR), a subsidiary of Merck, held its position as a No. 1 “Best Fast Weight-Loss Diet” in the 2017 Best Diets rankings released today by U.S. News & World Report. It’s the second year in a row HMR earned the top spot in the category, which was added to the annual rankings list last year.
“HMR’s highly structured diet and lifestyle change program is designed to help people lose weight quickly while learning the skills they need to keep it off,” said Carol Addy, M.D. MMSc, Chief Medical Officer at HMR. “Fast weight loss without lifestyle change isn’t sustainable. HMR gets fast weight loss, but our true expertise is helping people learn realistic ways to incorporate new healthy behaviors into their everyday lives.”
To view the multimedia release go to:
http://www.multivu.com/players/English/8003751-hmr-best-fast-weight-loss-diet-2017/
On World Mental Health Day, Janssen has announced the results of a pan-European research project: ‘Talking About Treatment in Schizophrenia: A Patient and Carer Survey’. The survey of 166 adults living with schizophrenia and 468 carers was conducted by the independent market research agency, Fieldwork International (part of Ipsos MORI), and explored awareness, feelings and preferences regarding treatment.
The survey, conducted across 12 countries in Europe (Austria, Belgium, Denmark, France, Germany, Italy, Netherlands, Russia, Spain, Sweden, Switzerland and the UK), highlighted key factors affecting the peace of mind for carers, such as the impact of the condition on day‑to-day life, potential relapse/hospitalisation and getting support beyond medication. 94% stated they reminded the person they care for to take their medication and for 49% this happens often.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7947151-janssen-survey-carers-adults-schizophrenia/
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.,* found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live. Results also showed that 95% of cancer patients surveyed believe that CINV has, at some point, had an impact on their daily lives. These national surveys are part of the Time to Talk CINV™ campaign, which aims to increase awareness among patients and caregivers about CINV prevention and the importance of speaking with their pharmacist and full healthcare team about this often preventable side effect.
“The survey results underscore the confusion patients who are undergoing chemotherapy have about CINV and the need for them to understand that there are ways to manage their symptoms so that they do not have to needlessly suffer with CINV,” said Scott Soefje, PharmD, MBA, BCOP, President, Hematology/Oncology Pharmacy Association (HOPA) and Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. “It is imperative that patients discuss CINV prevention early in treatment and with all members of the health care team, including pharmacists.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7560331-time-to-talk-cinv/
Invacare Corporation (NYSE:IVC), the global leader in home and long-term care medical products, today is launching “Real Life,” a new campaign dedicated to raising awareness of the everyday struggles and achievements of those living with disabilities, ailments or advancing age. For these individuals, even “ordinary” tasks like getting dressed, preparing for the day ahead, caring for children, driving a car or going to work can require extraordinary effort — yet few people are aware of these everyday struggles and achievements. Invacare has created this awareness campaign and platform so that people can share their ‘real life’ stories — or the story of someone who inspires them — for a chance to win cash prizes for themselves and the charity of their choice.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/invacare/49159/
Today, Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic treatments, announced the arrival of its groundbreaking Liposonix technology in the United States and Canada. Using advanced high-intensity focused ultrasound (HIFU) technology, Liposonix is a non-surgical permanent fat reduction procedure that has been clinically shown to slim down the waistline by one pant or dress size without surgery or downtime. It is indicated for non-invasive waist circumference reduction for use on both the abdomen and love handles.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54037-solta-liposonix-custom-contouring-waistline-fat-reduction
Companies in every part of the nation sponsor tax-qualified benefit plans to attract and retain high quality employees. The plans are designed to offer employees tax relief as they build up their retirement through 401k plans or to buy medical and dental type benefits. However, according to EisnerAmper's Pension Services Group, tax relief that benefits both the employer and the plan participants is at risk of being lost if plan sponsors fail to follow basic qualification requirements by maintaining effective internal control structures over their plans.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7461932-eisneramper-employee-benefits/
After only 16 weeks of existence, foetuses hear and respond to music as long as it is emitted from their mother’s vagina. Foetuses respond to this stimulus by opening their mouths and pulling their tongues out as far as possible, making vocalisation movements – prior to the acquisition of language.
This is the main conclusion of the study conducted by the team of Institut Marquès, which boasts the collaboration of Alberto Prats, Professor of Anatomy and Human Embryology of the Faculty of Medicine of the University of Barcelona.
The study, entitled “Foetal facial expression in response to intravaginal music emission”, is published this week in the journal Ultrasound of the British Medical Ultrasound Society (BMUS).
According to Dr. Marisa López-Teijón, the Head of Assisted Reproduction at Institut Marquès and the principal researcher and author of the clinical study: “We have discovered that the formula for foetuses to hear like us is to emit music from the mother’s vagina. They barely hear the sound that reaches them through their mother’s abdomen: the soft tissues of the abdomen and the inside of the mother’s body absorb the soundwaves”.
To view the multimedia release go to:
http://www.multivu.com/players/English/7647351-how-foetuses-hear-musical-stimuli/
Institut Marquès presents the 1000th birth of its international embryo adoption programme. It is a baby girl called Georgina who, with 3,500 kg. of weight, was born in the town of Essex (UK) last February. Her mother decided to adopt an embryo at Institut Marquès, a clinic in Barcelona, after having performed several cycles of assisted reproduction without success in different centres. In June, an embryo that had been frozen for years was transferred; it came from the treatment of a couple who did not answer about the destination they wanted for their embryos and they were thus left under the custody of the clinic.
Kerry Andersen, Georgina's mother, is a midwife. A 45-year-old single woman who believes that this treatment has given her "the best of my life, which was the hope of being a mother. I am thrilled to think that my precious daughter is here thanks to the embryo adoption programme as I feel it is a very special way to enjoy motherhood. When I got to know this program, I did not hesitate to adopt an embryo”.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8112351-institut-marques-women-spain-adopt-embryos/
In response to the growing need for quality healthcare in Chicago, Northwestern Medicine is proud to announce the opening of a new, one-million square foot outpatient pavilion at 259 E. Erie St. The new pavilion opened on Oct. 13 in the heart of Northwestern Medicine’s downtown medical campus, home to Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7049451-northwestern-medicine-to-open-259-east-erie-patient-pavilion-in-october/
